Free Trial

Bosun Asset Management LLC Sells 42,876 Shares of Oscar Health, Inc. (NYSE:OSCR)

Oscar Health logo with Finance background

Bosun Asset Management LLC decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 16.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 219,687 shares of the company's stock after selling 42,876 shares during the quarter. Oscar Health makes up approximately 1.3% of Bosun Asset Management LLC's holdings, making the stock its 14th largest holding. Bosun Asset Management LLC owned about 0.09% of Oscar Health worth $2,953,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of OSCR. Balyasny Asset Management L.P. bought a new position in shares of Oscar Health in the 4th quarter valued at about $1,992,000. BNP Paribas Financial Markets bought a new position in Oscar Health in the fourth quarter valued at approximately $590,000. Ameriprise Financial Inc. grew its holdings in Oscar Health by 3,062.3% during the 4th quarter. Ameriprise Financial Inc. now owns 976,563 shares of the company's stock worth $13,125,000 after acquiring an additional 945,682 shares during the period. Ancient Art L.P. raised its position in shares of Oscar Health by 66.8% during the 4th quarter. Ancient Art L.P. now owns 2,950,753 shares of the company's stock valued at $39,658,000 after acquiring an additional 1,182,134 shares during the last quarter. Finally, Ardsley Advisory Partners LP lifted its stake in shares of Oscar Health by 2.0% in the 4th quarter. Ardsley Advisory Partners LP now owns 1,125,000 shares of the company's stock valued at $15,120,000 after purchasing an additional 22,400 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Trading Up 0.3 %

Shares of OSCR traded up $0.05 during trading hours on Friday, reaching $17.11. The stock had a trading volume of 12,689,608 shares, compared to its average volume of 4,067,762. The company has a market cap of $4.29 billion, a P/E ratio of -855.07 and a beta of 1.75. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a 50-day moving average of $13.34 and a 200 day moving average of $14.64.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The company had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same quarter last year, the firm posted $0.62 earnings per share. Oscar Health's revenue was up 42.2% compared to the same quarter last year. On average, sell-side analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their price objective for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Oscar Health has a consensus rating of "Hold" and a consensus target price of $20.08.

Read Our Latest Analysis on OSCR

Oscar Health Company Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Recommended Stories

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines